BackMolecule Holdings Overview

Molecule Holdings Receivables

Molecule Holdings's receivables is $350K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$350000.00
↓ 50.55% YoYΔ $-357742.00 vs prior year quarter

Peer trimmed avg / median

Loading

Molecule Holdings Receivables History

Loading

Molecule Holdings vs. peers: Receivables Comparison

Loading

Molecule Holdings Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Molecule Holdings (MLCL.CN) FAQ

As of the most recent data (July 2023), MLCL.CN shows a receivables of $350K. That compares with $710K in the prior-year period — down 50.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MLCL.CN's receivables is now $350K (was $710K) — a 50.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Molecule Holdings is outperforming or lagging.

Tracking MLCL.CN's receivables over time shows whether Molecule Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $350K That compares with $710K in the prior-year period — down 50.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Molecule Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $350K) with ownership activity and broader fundamentals.